Earlier this month, Merck and Daiichi Sankyo announced that ifinatamab deruxtecan was granted Breakthrough Therapy Designation by the U.S. FDA for treating adult patients with extensive-stage small ...

AbbVie's oncology sales climbed 4.2% in H1 2025 as new drugs offset Imbruvica declines, strengthening its long-term growth outlook.

Aurobindo Pharma said it 'regularly explores' various strategic opportunities, including potential acquisitions and ...

Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 staff in Maryland.

A food additive made mass production of brain organoids possible. Researchers can now study development and disease at scale.

The Global Diabetic Neuropathy Market is expected to reach at a CAGR of 6.7% during the forecast period (2024-2031). The ...

TOKYO -- Japanese businesses are busy positioning themselves to soften the blow from the Trump administration's tariffs as the policy focus shifts from country-specific to industry-specific duties.